Great start to a fantastic exchange of scientific ideas with wonderful colleagues! #DAVAHeme DAVA Oncology

Excited to co-chair this event! Looking forward to talks from an outstanding faculty on the latest and greatest in malignant hematology! IDEOlogy Health Rutgers Cancer Institute

100 days to go!🎉 The countdown is on for the inaugural #NashvilleHeme25! Get ready for 2 days of cutting-edge insights, engaging discussions, and practical takeaways from top experts. Register for this CE accredited conference now! hubs.la/Q02XXX-n0 #CME #hematology

Great opportunity to share your research!

Thanks for the opportunity to moderate an outstanding panel on bispecific antibodies in the community! Rutgers Cancer Institute Mansi Shah Adrienne Phillips MD #CANCERNJ2024

Join 40+ Faculty members at the 2-Day CE Accredited Nashville Hematology Conference this Feb 20-22, 2025! Drs. drjoannarhodes and Jesus Berdeja, MD will co-chair this inaugural conference in Nashville, TN. Register today: hubs.la/Q02ZnT-H0 #MedEd #HemeTwitter

👏👏 Kudos to adult & pediatric Chiefs Matthew Matasar, MD & Peter Cole for GREAT achievement at the ASH #hematology symposium this year (6⃣6⃣ at the 6⃣6⃣th #ASH24). 🎉🎉An extra call-out to drjoannarhodes directing the #lymphoma program to nearly 50 lymphoid presentations!

Our first expert is here! Meet drjoannarhodes, Director of the Rutgers Cancer Institute RWJBarnabas Lymphoma Program. Dr. Rhodes will be at booth #3304 at #ASH24 until 2:30pm PST! ASH

Excited for the opportunity to be a part of this work examining the role of treatment sequencing on survival of CLL patients- CIT is not adequate and should be avoided where targeted agents are readily available- up to us to ensure they can be and are affordable Alan Skarbnik

Last call for abstracts for the inaugural Nashville Hematology Conference! Deadline Monday 12/16! ⁦Rutgers Cancer Institute⁩ ⁦IDEOlogy Health⁩ ⁦OneOncology⁩

Just out at AmericanJournalofHematology : Ven-based therapy after cBTKi in #CLL led by Nilanjan Ghosh, MD, PhD . Kudos to the CORE team and Beenish Manzoor for building the CORE registry. Looking forward to having more studies using CORE onlinelibrary.wiley.com/doi/full/10.10…

We want to hear from #teen and young adult #lymphoma survivors! Join the study "Social Genomic Mechanisms of Health Disparities among AYA Survivors of Hodgkin and Non-Hodgkin Lymphoma" Go to aftercancergenomics.org for more info.

Excited for the opportunity to co-chair this incredible program- can’t wait to hear all our faculty’s insights into the current and future landscape of care for heme malignancies! Nashville Hematology Conference Rutgers Cancer Institute

🚨Apparently all NIH Study Sections have been suspended indefinitely. For those who don’t know, this means there won’t be any review of grants submitted to NIH Depending on how long this goes on for, this could lead to an interruption in billions in research funding.

Had a great time presenting at the inaugural LLM Winter this week with friends and colleagues! Exciting to have participated in a panel with Andrew M. Evens, DO, MBA, MSc! Rutgers Cancer Institute Lymphoma, Leukemia & Myeloma Congress #LLMWinter #lysm

We’re officially one week away from the inaugural Nashville Hematology Conference! Join 40+ top experts and community practitioners in Nashville, TN for 2 days of engaging discussions on the latest updates and challenges in hematologic malignancies. Earn up to 12.5 #CE credits at

The Nashville Hematology Conference is just days away! Don’t miss the chance to engage with top experts, explore the latest in hematologic malignancies, and gain valuable insights at this 2-day #CE-accredited conference. Join us this Thursday in Nashville, TN. Registration is

Save the date! #NashvilleHeme26 returns February 26-28, 2026 to the iconic Country Music Hall of Fame® and Museum in Nashville. Don’t miss another anticipated CE conference with expert insights, engaging discussions, and valuable connections! Follow us to stay connected!

At Rutgers Cancer Institute RWJBarnabas, our experts are among the nation’s most experienced in treating blood cancers with immunotherapy and other cellular therapies, particularly the breakthrough cancer treatment CAR T-Cell therapy. cinj.org/patient-care/c…

Drs. Kieron Dunleavy , Francisco Hernandez-Ilizaliturri and drjoannarhodes presenting key updates in the management of high-grade B-cell lymphomas post #ASH24 #lymsm Roswell Park OncLive.com